School of Medicine
Showing 1,501-1,510 of 2,304 Results
-
Sabrina Orique
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioSabrina Orique, PhD, RN, AOCNS, is a hematology/oncology clinical nurse specialist at Stanford Health Care. She serves as adjunct faculty for Fresno Pacific University in the MSN FNP program. Her program of research entails patient safety with a focus on delivery of nursing care. Her published work includes missed nursing care, situation awareness, and early recognition of clinical deterioration. She has a Bachelor of Science in Nursing and a Master of Science in Nursing from California State University, Fresno. She earned her PhD in nursing from the University of Missouri, Columbia and is a 2015 Robert Wood Johnson Foundation Future of Nursing Scholar. She is a member of the National Association of Clinical Nurse Specialists, Oncology Nursing Society, and Sigma Theta Tau. She is certified as an oncology nurse and advanced oncology clinical nurse specialist by the Oncology Nursing Certification Cooperation.
-
Lars Osterberg, MD, MPH
Professor (Teaching) of Medicine (Primary Care and Population Health)
Current Research and Scholarly InterestsBarriers to Humanism
Collaborative Faculty Development in Improving Humanism and Professionalism
Using Radiofrequency Identificaton technology to improve medication adherence
Impact of Learning Communities on Medical Education -
Linda K. Ottoboni, PhD, CNS
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsLearning more about the patient lived experiences with cardiac arrhythmias and their perceived resources believed to provide support to achieve Quality of Life.
-
Laura A. Pace
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioI am a physician-scientist specializing in neuroimmunogastroenterology with a focus on the diagnosis and care of people suffering from complex multisystem disorders involving the neuroimmune axis. Neuroimmune axis disorders are conditions at the interface of the nervous and immune systems and often involve autonomic nervous system dysregulation, extracellular matrix|connective tissue dysregulation, endocrine dysregulation, and metabolic dysregulation. These conditions disproportionately and more severely impact females and often have an onset after an immune activating event such as an infection, surgery, concussion, or physical trauma. The complex, multisystem nature of these conditions requires the integration of information from multiple domains to diagnose and identify personalized therapeutic interventions. While at the University of Utah, I was part of the NIH Undiagnosed Diseases Network from 2017-2024, an experience that furthered my resolve to develop a precision medicine program focused on neuroimmune axis disorders. I am an ardent patient advocate and serve on the boards of several patient advocacy groups.
I am board certified in Internal Medicine and Gastroenterology through the American Board of Internal Medicine, and Autonomic Disorders through the United Council for Neurologic Subspecialties. Additionally, I have formalized clinical training in Neurogastroenterology and Medical Genetics, and a PhD in Neuroscience. I am a former NIH Building Interdisciplinary Careers in Women’s Health (BIRCWH) Scholar. To date I have published over 120 peer reviewed scientific articles and have received research funding from the NIH and private foundations.
My research has spanned the study of mammalian cell signaling; the physiology, ecology, and evolution of microbial metabolism; and human-microbe interactions leveraging multiomics. Through several collaborative multidisciplinary research projects her current work is focused on decoding the molecular and cellular mechanisms of neuroimmune axis disorders. Some of these exciting projects include the application of next-generation environmental microbiology techniques to understand the complex human-microbiota interactions at mucosal interfaces; identifying genetic and environmental contributions to neuroimmune axis disorders; and the development and application of novel therapeutics to treat these disabling disorders.
